The RELENT Project
The RELENT Project
The RELENT Project

Impact on public awareness

RELENT will, with the help of an undefinedAdvisory Board comprised of leading international authorities in science and medicine, together with representatives of Patients’ organisations and experts in Translational Medicine from industry implement a comprehensive strategy of undefineddissemination to reach out to the scientific community, those affected by autoimmune diseases, the stakeholders in Politics and Industry and the general public. undefinedRELENTS's Innovation and Exploitation Advisory Panel (IEAP) will regularly review the research programme's results for dissemination to the lay public and generate information material together with the members of the consortium that will be distributed

Therefore, partners of RELENT are actively promoting public awareness of novel research developments in the diagnosis and care of autoimmune diseases that might have a direct impact on patients' treatment.

RELENT Consortium

RELENT Partners
Search
Home
Menu
Top

News Section

The understanding of AAV pathogenesis isincreasing, leading to improvements in... Read more

Social Media

TwitterLinkedIn